Country: Malta
Language: English
Source: Medicines Authority
L, ORNITHINE, ASPARTATE
Merz Pharmaceuticals GmbH Eckenheimer Landstrasse 100, D-60318 Frankfurt am Main, Germany
A05BA
L-ORNITHINE 3 g/5g L-ASPARTATE 3 g/5g
GRANULES FOR ORAL SOLUTION
L-ORNITHINE 3 g/5g L-ASPARTATE 3 g/5g
POM
BILE AND LIVER THERAPY
Withdrawn
2006-11-08
Instructions for use, please read carefully! Composition: One 5 g sachet contains: Active ingredient: L-ornithine-L-aspartate 3 g Excipients: citric acid, saccharin sodium, sodium cyclamate, fructose, povidone 25, flavourings, colouring agent orange yellow S (E 110). Properties: Hepa-Merz granulate is a medicine which stimulates ammonia detoxification by increasing urea synthesis in the urea cycle. It serves extrahepatic ammonia detoxification in the tissues. Indications: Hepa-Merz granulate is used in the treatment of co-existing and subsequent disorders resulting from impaired detoxification activity in the liver (e.g. in cirrhosis of the liver) with symptoms of latent and manifest hepatic encephalopathy. Contraindications: Hepa-Merz granulate may not be taken: - if you react hypersensitively (allergically) to L-ornithine-L-aspartate, orange yellow S (E 110) or any of the other ingredients of Hepa-Merz granulate - if you suffer from severely impaired kidney function (renal insufficiency). A serum creatinine level exceeding 3 mg/100 ml can be regarded as a reference value - if you suffer from the rare, hereditary conditions of fructose intolerance, glucose-galactose malabsorption or sucrose- isomaltose deficiency. Side-effects: Like all medicines, Hepa-Merz granulate can cause side effects, although not everybody gets them. Nausea, vomiting, stomach ache, flatulence and diarrhoea are uncommon occurrences. In very rare cases, pain in the limbs has been observed. These side effects are usually transient and do not require withdrawal of the medicine. Orange yellow S (E 110) can trigger hypersensitivity reactions. If any of the side effects gets serious, or if you notice any side effects not listed in this leaflet, please tell your doctor or pharmacist. Interaction with other d Read the complete document
Page 1 of 5 SUMMARY OF PRODUCT CHARACTERISTICS 1. NAME OF THE MEDICINAL PRODUCT Hepa-Merz granules, 3 g/5 g Granules for oral solution 2. QUALITATIVE AND QUANTITATIVE COMPOSITION Active substance: L-ornithine L-aspartate. Each sachet with 5 g contains 3.0 g L-ornithine-L-aspartate. Excipients: yellow orange S (E 110) and fructose, see also chapter 4.4. For a full list of excipients, see section 6.1. 3. PHARMACEUTICAL FORM Granules for oral solution. The granules are orange in colour. 4. CLINICAL PARTICULARS 4.1 THERAPEUTIC INDICATIONS Treatment of concomitant disease and sequelae due to impaired hepatic detoxification activity (e.g. in cirrhosis of the liver) with the symptoms of latent and manifest hepatic encephalopathy. 4.2 POSOLOGY AND METHOD OF ADMINISTRATION Granules for oral solution. The dissolved contents of 1-2 sachets of Hepa-Merz granules are taken up to 3 times daily. Hepa-Merz granules are dissolved in plenty of fluid (e.g. a glass of water, tea or juice) and taken with or after meals. The experiences on the use of the drug in children are limited (see chapter 4.4). 4.3 CONTRAINDICATIONS Severely impaired renal function (renal insufficiency). A serum creatinine value over 3 mg / 100 ml can be used as a guideline value. Hepa-Merz granules may not be taken by patients with known hypersensitivity to L-ornithine-L- aspartate, orange yellow S or any of the excipients. Page 2 of 5 Patients with the rare hereditary conditions of fructose intolerance, glucose-galactose malabsorption or sucrose-isomaltose deficiency should not take Hepa-Merz granules. 4.4 SPECIAL WARNINGS AND SPECIAL PRECAUTIONS FOR USE This medicine contains the colouring agent orange yellow S (E 110), which can trigger allergic reactions. Hepa-Merz granules contain 1.13 g fructose per sachet (equivalent to 0.11 CEU Read the complete document